IDH1 and central nervous system cancer: In IDH‐mutant gliomas, the mutant IDHR132H produces 2‐HG, which accumulates and inhibits the lactate dehydrogenase of CD8+ T cells, thereby reducing glycolysis and disrupting the NAD+/NADH balance.